ArticleFrontiers in immunology2022

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients.

Ahreum Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.